Delivery Order SPE2DX22D0019-SPE2D826FCE80
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $40,717.64 by the Defense Logistics Agency's Medical Supply Chain on December 8, 2025. This firm fixed-price delivery order, which is expected to be completed by December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $943,263.97 by the Defense Logistics Agency's Medical Supply Chain on January 3, 2026. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, carries an ultimate completion date of January 5, 2026 and represents a non-competitive set-aside contract. The award supports the federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $53,658.52 by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle, is not set-aside and carries an ultimate completion date of December 12, 2025. The award reflects the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $102,646.24 on December 2, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of December 3, 2025, was awarded competitively with no set-aside designation. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,830.36 by the Defense Logistics Agency's Medical Supply Chain on November 30, 2025. This firm fixed price delivery order, which is a child contract under a larger vehicle, is scheduled for completion by December 1, 2025, and represents a non-competitive set-aside award. The contract reflects AmerisourceBergen's ongoing role as a critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,228.15 by the Defense Logistics Agency's Medical Supply Chain on December 9, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 10, 2025, and represents a child order under a larger indefinite delivery contract vehicle. The award is not set-aside and reflects the company's continued role...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,951.54 by the Defense Logistics Agency's Medical Supply Chain on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed price delivery order was awarded competitively without any set-aside designation and represents a task order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $343,309.98 by the Defense Logistics Agency's Medical Supply Chain on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price contract is a non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $33,186 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on December 29, 2025, with an ultimate completion date of December 30, 2025. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999 and...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D826FCE80Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,807 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under a larger indefinite delivery contract vehicle. The award is part of AmerisourceBergen's ongoing role as a critical federal medical procurement vendor, supplying pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s substantial indefinite delivery contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products, medical supplies, specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. The contract demonstrates Cencora/AmerisourceBergen's established capability to meet federal procurement requirements through competitive procurement processes and efficiently fulfill essential pharmaceutical and medical commodity needs for military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.8k | 1/5/26 |